speb/financial-data huggingface dataset:
AGNT income_statement (annual, 2022-12-31) — Cost Of Revenue: 4228503000.00
AGNT balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 13798000.00
AGNT balance_sheet (annual, 2022-12-31) — Current Assets: 255113000.00
AGNT balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 175000.00
AGNT balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 175000.00
AGNT balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 37789000.00
AGNT balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 37789000.00
AGNT balance_sheet (annual, 2022-12-31) — Current Liabilities: 127299000.00
AGNT cash_flow (annual, 2022-12-31) — Deferred Income Tax: -15848000.00
AGNT cash_flow (annual, 2022-12-31) — Deferred Tax: -15848000.00
AGNT cash_flow (annual, 2022-12-31) — Depreciation: 7934000.00
AGNT cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 9838000.00
AGNT cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 9838000.00
AGNT income_statement (annual, 2022-12-31) — Diluted Average Shares: 156220165.00
AGNT income_statement (annual, 2022-12-31) — Diluted EPS: 0.10
AGNT income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 15442000.00
AGNT income_statement (annual, 2022-12-31) — EBIT: 16357000.00
AGNT income_statement (annual, 2022-12-31) — EBITDA: 26195000.00
AGNT income_statement (annual, 2022-12-31) — Earnings From Equity Interest: -1624000.00
AGNT cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 1624000.00
AGNT cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -87000.00
AGNT cash_flow (annual, 2022-12-31) — End Cash Position: 159383000.00
AGNT cash_flow (annual, 2022-12-31) — Financing Cash Flow: -204514000.00
AGNT cash_flow (annual, 2022-12-31) — Free Cash Flow: 198484000.00
AGNT cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 361000.00
AGNT balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 236000.00
AGNT income_statement (annual, 2022-12-31) — General And Administrative Expense: 275445000.00
AGNT balance_sheet (annual, 2022-12-31) — Goodwill: 27212000.00
AGNT balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 35912000.00
AGNT balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 91276000.00
AGNT balance_sheet (annual, 2022-12-31) — Gross PPE: 39560000.00
AGNT income_statement (annual, 2022-12-31) — Gross Profit: 361173000.00
AGNT cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 3406000.00
AGNT balance_sheet (annual, 2022-12-31) — Invested Capital: 247823000.00
AGNT cash_flow (annual, 2022-12-31) — Investing Cash Flow: -22461000.00
AGNT balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 694000.00
AGNT balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 694000.00
AGNT balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 34226000.00
AGNT balance_sheet (annual, 2022-12-31) — Minority Interest: 1169000.00
AGNT income_statement (annual, 2022-12-31) — Minority Interests: 18000.00
AGNT cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -10410000.00
AGNT cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -179473000.00
AGNT income_statement (annual, 2022-12-31) — Net Income: 15442000.00
AGNT income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 15442000.00
AGNT income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 23735000.00
AGNT income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: -8311000.00
AGNT income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 15442000.00
AGNT income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 23753000.00
AGNT cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 15424000.00
AGNT income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 15424000.00
AGNT cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -424000.00
AGNT balance_sheet (annual, 2022-12-31) — Net PPE: 20278000.00
AGNT cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -12051000.00
AGNT balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 211911000.00
AGNT balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 68676000.00
AGNT balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 68676000.00
AGNT income_statement (annual, 2022-12-31) — Normalized EBITDA: 26195000.00
AGNT income_statement (annual, 2022-12-31) — Normalized Income: 23753000.00
AGNT cash_flow (annual, 2022-12-31) — Operating Cash Flow: 210535000.00
AGNT cash_flow (annual, 2022-12-31) — Operating Gains Losses: 1985000.00
AGNT income_statement (annual, 2022-12-31) — Operating Income: 16357000.00
AGNT income_statement (annual, 2022-12-31) — Operating Revenue: 4589676000.00
AGNT balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 152839239.00
AGNT balance_sheet (annual, 2022-12-31) — Other Current Assets: 580000.00
AGNT balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 236000.00
AGNT income_statement (annual, 2022-12-31) — Other Gand A: 275445000.00
AGNT income_statement (annual, 2022-12-31) — Other Income Expense: -821000.00
AGNT balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 8700000.00
AGNT balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 1703000.00
AGNT income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 803000.00
AGNT balance_sheet (annual, 2022-12-31) — Other Payable: 63022000.00
AGNT balance_sheet (annual, 2022-12-31) — Other Properties: 2127000.00
AGNT balance_sheet (annual, 2022-12-31) — Payables: 75537000.00
AGNT balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 89335000.00
AGNT balance_sheet (annual, 2022-12-31) — Prepaid Assets: 7888000.00
AGNT income_statement (annual, 2022-12-31) — Pretax Income: 15536000.00
AGNT cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 612000.00
AGNT cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 1816000.00
AGNT cash_flow (annual, 2022-12-31) — Purchase Of Business: -10410000.00
AGNT cash_flow (annual, 2022-12-31) — Purchase Of PPE: -12051000.00
AGNT balance_sheet (annual, 2022-12-31) — Receivables: 87262000.00
AGNT income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 4228503000.00
AGNT income_statement (annual, 2022-12-31) — Reconciled Depreciation: 9838000.00
AGNT cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -179473000.00
AGNT income_statement (annual, 2022-12-31) — Research And Development: 54199000.00
AGNT balance_sheet (annual, 2022-12-31) — Restricted Cash: 37789000.00
AGNT balance_sheet (annual, 2022-12-31) — Retained Earnings: 20723000.00
AGNT cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
AGNT income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 15172000.00
AGNT income_statement (annual, 2022-12-31) — Selling General And Administration: 290617000.00
AGNT balance_sheet (annual, 2022-12-31) — Share Issued: 171656030.00
AGNT income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
AGNT cash_flow (annual, 2022-12-31) — Stock Based Compensation: 209407000.00
AGNT balance_sheet (annual, 2022-12-31) — Stockholders Equity: 247823000.00
AGNT balance_sheet (annual, 2022-12-31) — Tangible Book Value: 211911000.00
AGNT income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
AGNT income_statement (annual, 2022-12-31) — Tax Provision: -8199000.00
AGNT income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
AGNT balance_sheet (annual, 2022-12-31) — Total Assets: 381682000.00
AGNT balance_sheet (annual, 2022-12-31) — Total Capitalization: 247823000.00
AGNT balance_sheet (annual, 2022-12-31) — Total Debt: 869000.00
AGNT balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 248992000.00
AGNT income_statement (annual, 2022-12-31) — Total Expenses: 4573319000.00
AGNT balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 132690000.00
AGNT balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 126569000.00
AGNT balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 5391000.00
AGNT income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 16357000.00
AGNT balance_sheet (annual, 2022-12-31) — Total Tax Payable: 2124000.00
AGNT income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
AGNT income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
AGNT balance_sheet (annual, 2022-12-31) — Tradeand Other Payables Non Current: 4697000.00
AGNT balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 18816791.00
AGNT balance_sheet (annual, 2022-12-31) — Treasury Stock: 385010000.00
AGNT balance_sheet (annual, 2022-12-31) — Working Capital: 127814000.00
AGNT income_statement (annual, 2022-12-31) — Write Off: 0.00
AGNT income_statement (annual, 2023-12-31) — +Operating Expense: 319402000.00
AGNT income_statement (annual, 2023-12-31) — +Total Revenue: 4273821000.00
AGNT balance_sheet (annual, 2023-12-31) — Accounts Payable: 8788000.00
AGNT balance_sheet (annual, 2023-12-31) — Accounts Receivable: 85343000.00
AGNT balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -27733000.00
AGNT balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 804833000.00
AGNT balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -2204000.00
AGNT cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 2540000.00
AGNT cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 2540000.00
AGNT cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 9203000.00
AGNT balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 1964000.00
AGNT income_statement (annual, 2023-12-31) — Basic Average Shares: 153232129.00
AGNT income_statement (annual, 2023-12-31) — Basic EPS: -0.06
AGNT cash_flow (annual, 2023-12-31) — Beginning Cash Position: 159383000.00
AGNT cash_flow (annual, 2023-12-31) — Capital Expenditure: -7957000.00
AGNT cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -2594000.00
AGNT balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 10000.00
AGNT balance_sheet (annual, 2023-12-31) — Capital Stock: 2000.00
AGNT balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 125873000.00
AGNT balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 125873000.00
AGNT cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -28519000.00
AGNT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -184089000.00
AGNT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -13503000.00
AGNT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 209131000.00
AGNT cash_flow (annual, 2023-12-31) — Change In Account Payable: -1491000.00
AGNT cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 8424000.00
AGNT cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 6919000.00
AGNT cash_flow (annual, 2023-12-31) — Change In Payable: -6168000.00
AGNT cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 2256000.00
AGNT cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -1263000.00
AGNT cash_flow (annual, 2023-12-31) — Change In Receivables: 3474000.00
AGNT cash_flow (annual, 2023-12-31) — Change In Working Capital: 11386000.00
AGNT cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 3474000.00
AGNT cash_flow (annual, 2023-12-31) — Changes In Cash: 11539000.00
AGNT balance_sheet (annual, 2023-12-31) — Common Stock: 2000.00
AGNT cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -28519000.00
AGNT balance_sheet (annual, 2023-12-31) — Common Stock Equity: 242839000.00
AGNT cash_flow (annual, 2023-12-31) — Common Stock Payments: -160550000.00
AGNT balance_sheet (annual, 2023-12-31) — Construction In Progress: 1013000.00
AGNT income_statement (annual, 2023-12-31) — Cost Of Revenue: 3953897000.00
AGNT balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 18111000.00
AGNT balance_sheet (annual, 2023-12-31) — Current Assets: 266475000.00
AGNT balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 10000.00
AGNT balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 10000.00
AGNT balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 44550000.00
AGNT balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 44550000.00
AGNT balance_sheet (annual, 2023-12-31) — Current Liabilities: 141660000.00
AGNT cash_flow (annual, 2023-12-31) — Deferred Income Tax: -2666000.00
AGNT cash_flow (annual, 2023-12-31) — Deferred Tax: -2666000.00
AGNT cash_flow (annual, 2023-12-31) — Depreciation: 8352000.00
AGNT cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 10892000.00
AGNT cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 10892000.00
AGNT income_statement (annual, 2023-12-31) — Diluted Average Shares: 156773528.00
AGNT income_statement (annual, 2023-12-31) — Diluted EPS: -0.06
AGNT income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -8973000.00
AGNT income_statement (annual, 2023-12-31) — EBIT: 522000.00
AGNT income_statement (annual, 2023-12-31) — EBITDA: 11414000.00
AGNT income_statement (annual, 2023-12-31) — Earnings From Equity Interest: -1388000.00
AGNT cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 1388000.00
AGNT cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -38000.00
AGNT cash_flow (annual, 2023-12-31) — End Cash Position: 170884000.00
AGNT cash_flow (annual, 2023-12-31) — Financing Cash Flow: -184089000.00
AGNT cash_flow (annual, 2023-12-31) — Free Cash Flow: 201174000.00
AGNT cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 472000.00
AGNT balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 332000.00
AGNT income_statement (annual, 2023-12-31) — General And Administrative Expense: 247799000.00
AGNT balance_sheet (annual, 2023-12-31) — Goodwill: 16982000.00
AGNT balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 23994000.00
AGNT balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 87547000.00
AGNT balance_sheet (annual, 2023-12-31) — Gross PPE: 40700000.00
AGNT income_statement (annual, 2023-12-31) — Gross Profit: 319924000.00
AGNT cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 2731000.00
AGNT balance_sheet (annual, 2023-12-31) — Invested Capital: 242839000.00
AGNT cash_flow (annual, 2023-12-31) — Investing Cash Flow: -13503000.00
AGNT balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 0.00
AGNT balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
AGNT balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 39687000.00
AGNT balance_sheet (annual, 2023-12-31) — Minority Interest: 1169000.00
AGNT income_statement (annual, 2023-12-31) — Minority Interests: 0.00
AGNT cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -5546000.00
AGNT cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -160550000.00
AGNT income_statement (annual, 2023-12-31) — Net Income: -8973000.00
AGNT income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -8973000.00
AGNT income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 3533000.00
AGNT income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: -12506000.00
AGNT income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -8973000.00
AGNT income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 3533000.00
AGNT cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -8973000.00
AGNT income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -8973000.00
AGNT balance_sheet (annual, 2023-12-31) — Net PPE: 12967000.00
AGNT cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -5363000.00
AGNT balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 218845000.00
AGNT balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 69253000.00
AGNT balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 69253000.00
AGNT income_statement (annual, 2023-12-31) — Normalized EBITDA: 11414000.00
AGNT income_statement (annual, 2023-12-31) — Normalized Income: 3533000.00
AGNT cash_flow (annual, 2023-12-31) — Operating Cash Flow: 209131000.00
AGNT cash_flow (annual, 2023-12-31) — Operating Gains Losses: 1860000.00
AGNT income_statement (annual, 2023-12-31) — Operating Income: 522000.00
AGNT income_statement (annual, 2023-12-31) — Operating Revenue: 4273821000.00
AGNT balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 154669037.00
AGNT balance_sheet (annual, 2023-12-31) — Other Current Assets: 1300000.00
AGNT balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 1809000.00
AGNT balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 332000.00
AGNT income_statement (annual, 2023-12-31) — Other Gand A: 247799000.00
AGNT income_statement (annual, 2023-12-31) — Other Income Expense: 2995000.00
AGNT balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 7012000.00
AGNT balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 12979000.00
AGNT income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 4383000.00
AGNT balance_sheet (annual, 2023-12-31) — Other Payable: 67195000.00
AGNT balance_sheet (annual, 2023-12-31) — Other Properties: 10000.00
AGNT balance_sheet (annual, 2023-12-31) — Payables: 77190000.00
AGNT balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 95301000.00
AGNT balance_sheet (annual, 2023-12-31) — Prepaid Assets: 7975000.00
AGNT income_statement (annual, 2023-12-31) — Pretax Income: 3517000.00
AGNT cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 4980000.00
AGNT cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: -1711000.00
AGNT cash_flow (annual, 2023-12-31) — Purchase Of Business: -5876000.00
AGNT cash_flow (annual, 2023-12-31) — Purchase Of PPE: -5363000.00
AGNT balance_sheet (annual, 2023-12-31) — Receivables: 85343000.00
AGNT income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 3953897000.00
AGNT income_statement (annual, 2023-12-31) — Reconciled Depreciation: 10892000.00
AGNT cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -160550000.00
AGNT income_statement (annual, 2023-12-31) — Research And Development: 59547000.00
AGNT balance_sheet (annual, 2023-12-31) — Restricted Cash: 44020000.00
AGNT balance_sheet (annual, 2023-12-31) — Retained Earnings: -16769000.00
AGNT cash_flow (annual, 2023-12-31) — Sale Of Business: 330000.00
AGNT income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 12056000.00
AGNT income_statement (annual, 2023-12-31) — Selling General And Administration: 259855000.00
AGNT balance_sheet (annual, 2023-12-31) — Share Issued: 183606708.00
AGNT income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
AGNT cash_flow (annual, 2023-12-31) — Stock Based Compensation: 189140000.00
AGNT balance_sheet (annual, 2023-12-31) — Stockholders Equity: 242839000.00
AGNT balance_sheet (annual, 2023-12-31) — Tangible Book Value: 218845000.00
AGNT income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
AGNT income_statement (annual, 2023-12-31) — Tax Provision: -16000.00
AGNT income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
AGNT balance_sheet (annual, 2023-12-31) — Total Assets: 385668000.00
AGNT balance_sheet (annual, 2023-12-31) — Total Capitalization: 242839000.00
AGNT balance_sheet (annual, 2023-12-31) — Total Debt: 10000.00
AGNT balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 244008000.00
AGNT income_statement (annual, 2023-12-31) — Total Expenses: 4273299000.00
AGNT balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 141660000.00
AGNT balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 119193000.00
AGNT balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
AGNT income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 522000.00
AGNT balance_sheet (annual, 2023-12-31) — Total Tax Payable: 1207000.00
AGNT income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
AGNT income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
AGNT balance_sheet (annual, 2023-12-31) — Tradeand Other Payables Non Current: 20000.00
AGNT balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 28937671.00
AGNT balance_sheet (annual, 2023-12-31) — Treasury Stock: 545559000.00
AGNT balance_sheet (annual, 2023-12-31) — Working Capital: 124815000.00
AGNT income_statement (annual, 2023-12-31) — Write Off: 0.00
AGNT balance_sheet (quarterly, 2024-09-30) — Assets Held For Sale Current: 988000.00
AGNT balance_sheet (quarterly, 2024-09-30) — Minority Interest: 0.00
AGNT cash_flow (quarterly, 2024-09-30) — Net Other Financing Charges: 0.00
AGNT balance_sheet (quarterly, 2024-09-30) — Other Properties: -5000.00
AGNT income_statement (quarterly, 2024-09-30) — Other Special Charges: 18000000.00
AGNT balance_sheet (quarterly, 2024-09-30) — Tradeand Other Payables Non Current: 0.00
AGNT income_statement (annual, 2024-12-31) — +Operating Expense: 322459000.00
AGNT income_statement (annual, 2024-12-31) — +Total Revenue: 4567672000.00
AGNT balance_sheet (annual, 2024-12-31) — Accounts Payable: 10478000.00
AGNT balance_sheet (annual, 2024-12-31) — Accounts Receivable: 87692000.00
AGNT balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -35262000.00
AGNT balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 962758000.00
AGNT balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -1589000.00
AGNT cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 2454000.00
AGNT cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 2454000.00
AGNT cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 4930000.00
AGNT balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 0.00
AGNT balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 0.00
AGNT income_statement (annual, 2024-12-31) — Basic Average Shares: 153684907.00
AGNT income_statement (annual, 2024-12-31) — Basic EPS: -0.14
AGNT cash_flow (annual, 2024-12-31) — Beginning Cash Position: 169893000.00
AGNT cash_flow (annual, 2024-12-31) — Capital Expenditure: -7873000.00
AGNT cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -1390000.00
AGNT balance_sheet (annual, 2024-12-31) — Capital Stock: 2000.00
AGNT balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 113607000.00
AGNT balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 113607000.00
AGNT cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -30099000.00
AGNT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -170377000.00
AGNT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -19470000.00
AGNT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 191514000.00
AGNT cash_flow (annual, 2024-12-31) — Change In Account Payable: 1690000.00
AGNT cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -1445000.00
AGNT cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 45164000.00
AGNT cash_flow (annual, 2024-12-31) — Change In Payable: 1690000.00
AGNT cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 245000.00
AGNT cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 3041000.00
AGNT cash_flow (annual, 2024-12-31) — Change In Receivables: -1704000.00
AGNT cash_flow (annual, 2024-12-31) — Change In Working Capital: 46746000.00
AGNT cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -1704000.00
AGNT cash_flow (annual, 2024-12-31) — Changes In Cash: 1667000.00
AGNT balance_sheet (annual, 2024-12-31) — Common Stock: 2000.00
AGNT cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -30099000.00
AGNT balance_sheet (annual, 2024-12-31) — Common Stock Equity: 204869000.00
AGNT cash_flow (annual, 2024-12-31) — Common Stock Payments: -141121000.00
AGNT balance_sheet (annual, 2024-12-31) — Construction In Progress: 593000.00
AGNT income_statement (annual, 2024-12-31) — Cost Of Revenue: 4225277000.00
AGNT balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 15059000.00
AGNT balance_sheet (annual, 2024-12-31) — Current Assets: 267972000.00
AGNT balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 55660000.00
AGNT balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 55660000.00
AGNT balance_sheet (annual, 2024-12-31) — Current Liabilities: 185853000.00
AGNT cash_flow (annual, 2024-12-31) — Deferred Income Tax: -6521000.00
AGNT cash_flow (annual, 2024-12-31) — Deferred Tax: -6521000.00
AGNT cash_flow (annual, 2024-12-31) — Depreciation: 7835000.00
AGNT cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 10289000.00
AGNT cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 10289000.00
AGNT income_statement (annual, 2024-12-31) — Diluted Average Shares: 153684907.00
AGNT income_statement (annual, 2024-12-31) — Diluted EPS: -0.14
AGNT income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -21267000.00
AGNT income_statement (annual, 2024-12-31) — EBIT: 19936000.00
AGNT income_statement (annual, 2024-12-31) — EBITDA: 30225000.00
AGNT income_statement (annual, 2024-12-31) — Earnings From Equity Interest: -1168000.00
AGNT cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: 1168000.00
AGNT cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -2972000.00
AGNT cash_flow (annual, 2024-12-31) — End Cash Position: 168588000.00
AGNT cash_flow (annual, 2024-12-31) — Financing Cash Flow: -170377000.00
AGNT cash_flow (annual, 2024-12-31) — Free Cash Flow: 183641000.00
AGNT cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 266000.00
AGNT cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of Business: 266000.00
AGNT balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -3076000.00
AGNT income_statement (annual, 2024-12-31) — General And Administrative Expense: 252369000.00
AGNT balance_sheet (annual, 2024-12-31) — Goodwill: 17226000.00
AGNT balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 23682000.00
AGNT balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 89281000.00
AGNT balance_sheet (annual, 2024-12-31) — Gross PPE: 46877000.00
AGNT income_statement (annual, 2024-12-31) — Gross Profit: 342395000.00
AGNT cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 2694000.00
AGNT balance_sheet (annual, 2024-12-31) — Invested Capital: 204869000.00
AGNT cash_flow (annual, 2024-12-31) — Investing Cash Flow: -19470000.00
AGNT balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 46284000.00
AGNT balance_sheet (annual, 2024-12-31) — Minority Interest: 0.00
AGNT balance_sheet (quarterly, 2024-12-31) — Minority Interest: 0.00
AGNT income_statement (annual, 2024-12-31) — Minority Interests: 0.00
AGNT cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -11597000.00
AGNT cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -141121000.00
AGNT income_statement (annual, 2024-12-31) — Net Income: -21267000.00
AGNT income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -21267000.00
AGNT income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -16788000.00
AGNT income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: -4479000.00
AGNT income_statement (quarterly, 2024-12-31) — Net Income Discontinuous Operations: -1262000.00
AGNT income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -21267000.00
AGNT income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -16788000.00
AGNT cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -21267000.00
AGNT income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -21267000.00
AGNT cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -1169000.00
AGNT cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: 0.00
AGNT balance_sheet (annual, 2024-12-31) — Net PPE: 11615000.00
AGNT cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -6483000.00
AGNT balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 181187000.00
AGNT balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 75774000.00
AGNT balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 75774000.00
AGNT income_statement (annual, 2024-12-31) — Normalized EBITDA: 69155000.00
AGNT income_statement (annual, 2024-12-31) — Normalized Income: 13966700.00
AGNT cash_flow (annual, 2024-12-31) — Operating Cash Flow: 191514000.00
AGNT cash_flow (annual, 2024-12-31) — Operating Gains Losses: 1434000.00
AGNT income_statement (annual, 2024-12-31) — Operating Income: 19936000.00
AGNT income_statement (annual, 2024-12-31) — Operating Revenue: 4567672000.00
AGNT balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 154133385.00
AGNT balance_sheet (annual, 2024-12-31) — Other Current Assets: 1189000.00
AGNT balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 34054000.00
AGNT balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -3076000.00
AGNT income_statement (annual, 2024-12-31) — Other Gand A: 252369000.00
AGNT income_statement (annual, 2024-12-31) — Other Income Expense: -35653000.00
AGNT balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 6456000.00
AGNT balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 11679000.00
AGNT income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 4445000.00
AGNT balance_sheet (annual, 2024-12-31) — Other Payable: 66603000.00
AGNT balance_sheet (quarterly, 2024-12-31) — Other Payable: 66603000.00
AGNT income_statement (annual, 2024-12-31) — Other Special Charges: 34000000.00
AGNT income_statement (quarterly, 2024-12-31) — Other Special Charges: 0.00
AGNT balance_sheet (annual, 2024-12-31) — Payables: 81080000.00
AGNT balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 96139000.00
AGNT balance_sheet (annual, 2024-12-31) — Prepaid Assets: 10503000.00
AGNT balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 10503000.00
AGNT income_statement (annual, 2024-12-31) — Pretax Income: -15717000.00
AGNT cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 2012000.00
AGNT cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: -615000.00
AGNT cash_flow (annual, 2024-12-31) — Purchase Of Business: -11597000.00
AGNT cash_flow (quarterly, 2024-12-31) — Purchase Of Business: -4211000.00
AGNT cash_flow (annual, 2024-12-31) — Purchase Of PPE: -6483000.00
AGNT balance_sheet (annual, 2024-12-31) — Receivables: 87692000.00
AGNT income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 4225277000.00
AGNT income_statement (annual, 2024-12-31) — Reconciled Depreciation: 10289000.00
AGNT cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -141121000.00
AGNT income_statement (annual, 2024-12-31) — Research And Development: 58182000.00
AGNT balance_sheet (annual, 2024-12-31) — Restricted Cash: 54981000.00
AGNT balance_sheet (annual, 2024-12-31) — Retained Earnings: -68135000.00
AGNT cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
AGNT cash_flow (quarterly, 2024-12-31) — Sale Of Business: 0.00
AGNT income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 11908000.00
AGNT income_statement (annual, 2024-12-31) — Selling General And Administration: 264277000.00
AGNT balance_sheet (annual, 2024-12-31) — Share Issued: 195028207.00
AGNT income_statement (annual, 2024-12-31) — Special Income Charges: -38930000.00
AGNT income_statement (quarterly, 2024-12-31) — Special Income Charges: -4930000.00
AGNT cash_flow (annual, 2024-12-31) — Stock Based Compensation: 156518000.00
AGNT balance_sheet (annual, 2024-12-31) — Stockholders Equity: 204869000.00
AGNT balance_sheet (annual, 2024-12-31) — Tangible Book Value: 181187000.00
AGNT income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -8175300.00
AGNT income_statement (annual, 2024-12-31) — Tax Provision: 1071000.00
AGNT income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
AGNT balance_sheet (annual, 2024-12-31) — Total Assets: 390722000.00
AGNT balance_sheet (annual, 2024-12-31) — Total Capitalization: 204869000.00
AGNT balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 204869000.00
AGNT income_statement (annual, 2024-12-31) — Total Expenses: 4547736000.00
AGNT balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 185853000.00
AGNT balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 122750000.00
AGNT balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
AGNT income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -18994000.00
AGNT balance_sheet (annual, 2024-12-31) — Total Tax Payable: 3999000.00
AGNT balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 3999000.00
AGNT income_statement (annual, 2024-12-31) — Total Unusual Items: -38930000.00
AGNT income_statement (quarterly, 2024-12-31) — Total Unusual Items: -4930000.00
AGNT income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -38930000.00
AGNT income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -4930000.00
AGNT balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 40894822.00
AGNT balance_sheet (annual, 2024-12-31) — Treasury Stock: 686680000.00
AGNT balance_sheet (annual, 2024-12-31) — Working Capital: 82119000.00
AGNT income_statement (annual, 2024-12-31) — Write Off: 4930000.00
AGNT income_statement (quarterly, 2025-03-31) — +Operating Expense: 86511000.00
AGNT income_statement (quarterly, 2025-03-31) — +Total Revenue: 954906000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 10109000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 104045000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -37220000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 993164000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -2194000.00
AGNT cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 616000.00
AGNT cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 616000.00
AGNT income_statement (quarterly, 2025-03-31) — Basic Average Shares: 154738167.00
AGNT income_statement (quarterly, 2025-03-31) — Basic EPS: -0.07
AGNT cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 168588000.00
AGNT cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -3003000.00
AGNT cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -450000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Capital Stock: 2000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 115655000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 115655000.00
AGNT cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -7602000.00
AGNT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -12284000.00
AGNT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -14247000.00
AGNT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 39838000.00
AGNT cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -369000.00
AGNT cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 25828000.00
AGNT cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 11869000.00
AGNT cash_flow (quarterly, 2025-03-31) — Change In Payable: -369000.00
AGNT cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 25459000.00
AGNT cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -2963000.00
AGNT cash_flow (quarterly, 2025-03-31) — Change In Receivables: -15808000.00
AGNT cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 18557000.00
AGNT cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -15808000.00
AGNT cash_flow (quarterly, 2025-03-31) — Changes In Cash: 13307000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Common Stock: 2000.00
AGNT cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -7602000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 211980000.00
AGNT cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -4982000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 1176000.00
AGNT income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 878771000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 112111000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Current Assets: 300924000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 67345000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 67345000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 223803000.00
AGNT cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -1509000.00
AGNT cash_flow (quarterly, 2025-03-31) — Deferred Tax: -1509000.00
AGNT cash_flow (quarterly, 2025-03-31) — Depreciation: 1945000.00
AGNT cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 2561000.00
AGNT cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 2561000.00
AGNT income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 154738167.00
AGNT income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.07
AGNT income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -11024000.00
AGNT income_statement (quarterly, 2025-03-31) — EBIT: -10376000.00
AGNT income_statement (quarterly, 2025-03-31) — EBITDA: -7815000.00
AGNT income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 80000.00
AGNT cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: -80000.00
AGNT cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 329000.00
AGNT cash_flow (quarterly, 2025-03-31) — End Cash Position: 182224000.00
AGNT cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -12284000.00
AGNT cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 36835000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -2763000.00
AGNT income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 66871000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Goodwill: 17263000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 23514000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 106239000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Gross PPE: 49429000.00
AGNT income_statement (quarterly, 2025-03-31) — Gross Profit: 76135000.00
AGNT cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 1480000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Invested Capital: 211980000.00
AGNT cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -14247000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 48253000.00
AGNT cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -11244000.00
AGNT cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -4982000.00
AGNT income_statement (quarterly, 2025-03-31) — Net Income: -11024000.00
AGNT income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -11024000.00
AGNT income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -11024000.00
AGNT income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: 0.00
AGNT income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -11024000.00
AGNT income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -11024000.00
AGNT cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -11024000.00
AGNT income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -11024000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Net PPE: 12209000.00
AGNT cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -2553000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 188466000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 77283000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 77283000.00
AGNT income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -7815000.00
AGNT income_statement (quarterly, 2025-03-31) — Normalized Income: -11024000.00
AGNT cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 39838000.00
AGNT cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -80000.00
AGNT income_statement (quarterly, 2025-03-31) — Operating Income: -10376000.00
AGNT income_statement (quarterly, 2025-03-31) — Operating Revenue: 954906000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 156169130.00
AGNT balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 14655000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 34238000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -2763000.00
AGNT income_statement (quarterly, 2025-03-31) — Other Gand A: 66871000.00
AGNT income_statement (quarterly, 2025-03-31) — Other Income Expense: 1023000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 6251000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 21853000.00
AGNT income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 943000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Payables: 10109000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 122220000.00
AGNT income_statement (quarterly, 2025-03-31) — Pretax Income: -9353000.00
AGNT cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 300000.00
AGNT cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 605000.00
AGNT cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -11244000.00
AGNT cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -2553000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Receivables: 104045000.00
AGNT income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 878771000.00
AGNT income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 2561000.00
AGNT cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -4982000.00
AGNT income_statement (quarterly, 2025-03-31) — Research And Development: 16805000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 66569000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -86761000.00
AGNT income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 2835000.00
AGNT income_statement (quarterly, 2025-03-31) — Selling General And Administration: 69706000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Share Issued: 197536271.00
AGNT income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
AGNT cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 30728000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 211980000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 188466000.00
AGNT income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
AGNT income_statement (quarterly, 2025-03-31) — Tax Provision: 1671000.00
AGNT income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
AGNT balance_sheet (quarterly, 2025-03-31) — Total Assets: 435783000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 211980000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 211980000.00
AGNT income_statement (quarterly, 2025-03-31) — Total Expenses: 965282000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 223803000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 134859000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
AGNT income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -10376000.00
AGNT income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
AGNT income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
AGNT balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 41367141.00
AGNT balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 691662000.00
AGNT balance_sheet (quarterly, 2025-03-31) — Working Capital: 77121000.00
AGNT income_statement (quarterly, 2025-06-30) — +Operating Expense: 95030000.00
AGNT income_statement (quarterly, 2025-06-30) — +Total Revenue: 1308877000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 11286000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 146193000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -38838000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1031660000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -2271000.00
AGNT cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 685000.00
AGNT cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 685000.00
AGNT income_statement (quarterly, 2025-06-30) — Basic Average Shares: 156091692.00
AGNT income_statement (quarterly, 2025-06-30) — Basic EPS: -0.01
AGNT cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 182224000.00
AGNT cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -2531000.00
AGNT cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: 267000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Capital Stock: 2000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 94551000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 94551000.00
AGNT cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -7671000.00
AGNT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -32482000.00
AGNT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -2960000.00
AGNT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 36088000.00
AGNT cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 1177000.00
AGNT cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 32866000.00
AGNT cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 5435000.00
AGNT cash_flow (quarterly, 2025-06-30) — Change In Payable: 1177000.00
AGNT cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 34043000.00
AGNT cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 825000.00
AGNT cash_flow (quarterly, 2025-06-30) — Change In Receivables: -42225000.00
AGNT cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -1922000.00
AGNT cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -42225000.00
AGNT cash_flow (quarterly, 2025-06-30) — Changes In Cash: 646000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Common Stock: 2000.00
AGNT cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -7671000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 218366000.00
AGNT cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -24887000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 1229000.00
AGNT income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1216223000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 144576000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Current Assets: 344957000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 90004000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 90004000.00